New study aims to tailor ovarian cancer treatment for women over 70
NCT ID NCT06572735
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 50 women aged 70 and older with advanced ovarian cancer who are starting PARP inhibitors for the first time. Researchers will track how much of the planned dose patients actually receive, and look at factors like age, genetics, and overall health that might affect tolerance. The goal is to better understand how to manage side effects and keep patients on effective treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PARP inhibitors
- What this could lead to
- If successful, this could help doctors better manage side effects and dosing of PARP inhibitors in elderly patients, potentially improving treatment outcomes.
- What could go wrong
- This is a small observational study (50 patients) that does not test a new treatment. It only gathers data, so it will not directly change care immediately.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Georges François Leclerc
RECRUITINGDijon, 21079, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Hospitalier Privé Saint-Grégoire - Les Hôpitaux Privés Rennais
RECRUITINGSaint-Grégoire, 35760, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
RECRUITINGAmiens, 80054, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Hospitalier Valence
RECRUITINGValence, 26953, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre de lutte contre le cancer Jean Perrin
RECRUITINGClermont-Ferrand, 63011, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Clinique Mathilde
RECRUITINGRouen, 76100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinique de l'Europe
RECRUITINGAmiens, 80090, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Groupe Hospitalier Diaconesses Croix Saint Simon
RECRUITINGParis, 75020, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Groupe Hospitalier Public Sud de l'Oise
RECRUITINGCreil, 60100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Femme-Mère-Enfant
RECRUITINGBron, 69500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Privé Jean Mermoz
RECRUITINGLyon, 69008, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut de Cancérologie et d'Hématologie Universitaire de Saint Etienne
RECRUITINGSaint-Priest-en-Jarez, 42271, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Médipôle Hôpital Mutualiste
RECRUITINGVilleurbanne, 69100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service Hôpital de jour / Oncologie Médicale, Hôpital de la Croix Rousse
RECRUITINGLyon, 69004, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Service Oncologie Médicale, Hôpital Lyon Sud
RECRUITINGPierre-Bénite, 69495, France
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service de Gériatrie, Hôpital Dr Frédéric Dugoujon
RECRUITINGLyon, 69317, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Chest-Injected drug drain Cancer's fluid trap?
- Can a pill that blocks multiple cancer proteins shrink Hard-to-Treat tumors?
- Can a custom mRNA vaccine keep ovarian cancer from coming back?
- Can a cancer pill keep working outside the lab? a Real-World test begins
- Can a Patient's own immune cells be supercharged to fight ovarian cancer?
- Can a new drug ST316 shrink Hard-to-Treat tumors?